{"id":"W2903347258","doi":"10.2337/dc18-1491","title":"Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Esperion Therapeutics; Ionis Pharmaceuticals; Mylan; Novo Nordisk; Medicines Company; Sanofi; Kowa Company; Regeneron Pharmaceuticals; Eli Lilly and Company; AstraZeneca; CSL Behring; Amgen; Pfizer","keywords":"PCSK9; Medicine; Diabetes mellitus; Dyslipidemia; Internal medicine; Placebo; Adverse effect; Cholesterol; Endocrinology; Type 2 diabetes; Apolipoprotein B; Randomized controlled trial; Lipoprotein; Gastroenterology; LDL receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001749684,0.001535499,0.002306122,0.0003327597,0.0002789874,0.0009293017,0.0006922144,0.001387624,0.006720471],"category_scores_gemma":[0.001850193,0.0004635241,0.001279748,0.0003127452,0.0007266935,0.0008074435,0.0003756251,0.001924124,0.0006373185],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005259422,"about_ca_system_score_gemma":0.0005851031,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003956732,"about_ca_topic_score_gemma":0.00101411,"domain_scores_codex":[0.9993155,0.0003678708,0.00005523208,0.0001297792,0.00004514278,0.00008642235],"domain_scores_gemma":[0.9992743,0.0001788385,0.0002646756,0.00005996293,0.00004280407,0.0001793902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.986064,0.002078968,0.0008599375,0.0004078228,0.0006979431,0.00002892303,0.00001743446,0.0000997573,0.001380539,0.00006748938,0.0003783225,0.007918909],"study_design_scores_gemma":[0.9515522,0.04215483,0.003598551,0.00006116853,0.001267748,0.00004965492,0.00001721004,0.0002593948,0.0004019403,0.0001135072,0.0005093046,0.00001462483],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887138,0.006336206,0.0002280706,0.0005497759,0.0003124597,0.001066363,0.0006272452,0.00006101992,0.00210502],"genre_scores_gemma":[0.9886254,0.003304196,0.0007796389,0.0008852363,0.0004617631,0.0015277,0.001227212,0.00001596062,0.003173014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006720471,"threshold_uncertainty_score":0.02248228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02028013790582422,"score_gpt":0.3205581695925471,"score_spread":0.3002780316867228,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}